Christopher R. Cline, CHIEF FINANCIAL OFFICER at Travere Therapeutics, Inc. (TVTX), sold 7,242 shares at $32.12 ($233K) on 2026-02-03, disclosed to the SEC on 2026-02-03.
Seasonal sale ($233k) by CHIEF FINANCIAL OFFICER — this insider has traded TVTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| TVTX | SELL | 2026-05-06 | $115K | — | Filing → |
| TVTX | SELL | 2026-04-15 | $349K | — | Filing → |
| TVTX | SELL | 2026-02-05 | $56K | — | Filing → |